CLINICAL_TRIALS
research
· 2015-03-31
Clinical Trial Update: A Multi-center Randomized Controlled Trial of Intraportal Chemotherapy Combined With Adjuvant Chemotherapy (mFOLFOX6) for Stage II and III Colon Cancer [Phase 3]
Summary
This document reports a Phase 3 multi-center randomized trial evaluating intraportal chemotherapy combined with the mFOLFOX6 adjuvant regimen for Stage II-III c…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Xu jianmin | Conditions: Colorectal Cancer, Metastasis | Phase 3 | Status: UNKNOWN